GlassScriptPhysician profile
Fernando M Safdie
NPI 1881956944
$20,323.02
in general payments reported to CMS, 2019-2025
28 companies · $3,845 in 2025
The $3,845 reported for 2025 was more than what 88% of Surgery providers received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $7,888 · 2020: $1,536 · 2021: $1,727 · 2022: $1,724 · 2023: $2,709 · 2024: $892 · 2025: $3,845.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,821 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $1,500 · Travel and Lodging: $971 · Education: $155.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,821.07 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $1,500.00 |
| Travel and Lodging | $971.46 |
| Education | $154.72 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $13,996.11 | 2019-2025 | Da Vinci Surgical System |
| Atricure, INC. | $2,373.43 | 2019-2025 | Atricure Cryoice Cryosphere Cryoablation System, Atricure Cryoice Cryoablation System (Cryo2), Atriclip Laa Exclusion System |
| Davol INC. | $774.75 | 2019-2025 | Progel Applicator Spray Tips |
| Edwards Lifesciences Corporation | $684.17 | 2022-2025 | Mitris Resilia Mitral Valve, Konect Resilia |
| Medtronic, INC. | $480.21 | 2021-2024 | Illumisite |
| Ethicon INC. | $311.81 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $186.66 | 2019-2023 | Opdivo |
| Ambu INC. | $185.02 | 2021-2022 | |
| Lsi Solutions INC | $177.32 | 2019-2022 | |
| Olympus America INC. | $150.00 | 2022 | |
| Baxter Healthcare | $142.63 | 2025 | Perclot |
| Tempus Ai, INC | $120.65 | 2025 | Xt Cdx |
| Medtronic Vascular, INC. | $119.00 | 2019 | |
| Abiomed | $98.18 | 2025 | |
| Lexington Medical, INC. | $94.36 | 2023 | Aeon Endostapler & Echelon Flex Powered Stapler |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Covidien LP | $62.53 | 2019 | |
| Kci USA, INC. | $52.63 | 2021-2023 | Prevena, V.A.C. Veraflo Cleanse Choice, V.A.C. Veraflo |
| Conmed Corporation | $50.00 | 2021 | |
| Astrazeneca Pharmaceuticals LP | $42.21 | 2019 | |
| Ethicon US, LLC | $41.73 | 2025 | Ethicon |
| Angiodynamics, INC. | $30.64 | 2022 | |
| Mallinckrodt Enterprises LLC | $27.99 | 2019 | |
| Abbott Laboratories | $25.99 | 2025 | Navitor |
| Takeda Pharmaceuticals U.S.A., INC. | $23.28 | 2019 | |
| Bard Peripheral Vascular, INC. | $19.66 | 2023 | |
| Solventum Corporation | $19.60 | 2024 | V.A.C. Veraflo Cleanse Choice, V.A.C.Ulta, Prevena |
| Merck Sharp & Dohme LLC | $16.98 | 2020 | |
| Celgene Corporation | $15.48 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Fernando Safdie listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.